Medical Condition News

RSS

Affectionate communication may have positive impact on alexithymia sufferers

Every person has some level of alexithymia, as it is the personality trait which keeps people from sharing or even understanding their own emotions. Now, one University of Missouri researcher's latest study indicates that affectionate communication, such as hugging, could help those who have high levels of alexithymia lead more fulfilling lives.

7 Apr 2011

Robotic-assisted keyhole surgery tested for bowel cancer

A robotic system that promises to improve the quality of 'keyhole' bowel cancer surgery is being put to the test for the first time.

7 Apr 2011

Elevated BMI linked to high risk of obesity-related disorders in young adults

A large cohort study following 37,000 teenagers for 17 years found that an elevated, yet normal range Body Mass Index constitutes a substantial risk factor for obesity-related disorders in young adults.

7 Apr 2011

Vegans at increased risk of developing blood clots and atherosclerosis

People who follow a vegan lifestyle - strict vegetarians who try to eat no meat or animal products of any kind - may increase their risk of developing blood clots and atherosclerosis or "hardening of the arteries," which are conditions that can lead to heart attacks and stroke. That's the conclusion of a review of dozens of articles published on the biochemistry of vegetarianism during the past 30 years. The article appears in ACS' bi-weekly Journal of Agricultural and Food Chemistry.

7 Apr 2011

Supplements are less well regulated than drugs and may have side effects, drug interactions and toxicities

Vitamins, herbs and other dietary supplements are sold as natural alternatives to pharmaceuticals and many people turn to them in an attempt to improve their health. Others seek supplements to lose weight or after hearing that they can help with serious medical conditions.

7 Apr 2011

EACPR to host sessions on Cardiovascular prevention in Russia at EuroPRevent meeting

This year's EuroPRevent meeting, 14 -16 April, is taking full advantage of its Geneva location and the close proximity to the European Headquarters of the World Health Organisation, the World Heart Federation, the United European Football Association, and the International Olympics Committee.

7 Apr 2011

Positive results from Neuros Medical Electrical Nerve Block technology study in chronic pain

Neuros Medical, Inc., a medical device company, announced promising results today from their recently completed feasibility study. The study was the first human test of the Company's patented high frequency Electrical Nerve Block™ technology and focused on patients with chronic amputation pain which affects nearly one million patients in the U.S. During the study, four of the five patients reported their pain was reduced to zero.

7 Apr 2011

New insight into Huntington's disease

Huntington's disease has long been linked to jerky movements. Now, researchers in Lund, Sweden, have shown that the metabolism can also be seriously affected by the hereditary disease. The new laboratory findings provide hope of entirely new treatment methods.

7 Apr 2011

Scientists identify cellular switch that may help treat cardiovascular disease, cancer

Scientists at the University of Hull have identified a cellular 'on-off' switch that may have implications for treating cardiovascular disease and cancer.

7 Apr 2011

New Pipeline Embolization Device receives FDA approval for treatment of brain aneurysms

The U.S. Food and Drug Administration today approved a new device that provides neurointerventional surgeons with another tool to treat brain aneurysms without performing open surgery.

7 Apr 2011

Cernostics, Definiens enter partnership to develop unique cancer assay

Definiens, the number one Health Image Intelligence company, and Cernostics, a life sciences firm specializing in advanced cancer diagnostics, today announced a partnership to develop a unique multiplexed assay tool for the diagnosis of cancer.

7 Apr 2011

ALR announces medical research grant awards to cure lupus

The Alliance for Lupus Research – the world's largest private funder of lupus research – today announced its most recent medical research grant awards, totaling $3.6 million, which support the ALR mission of finding better treatments and ultimately preventing and curing systemic lupus erythematosus, a debilitating autoimmune disease.

7 Apr 2011

USPTO issues notice of allowance to Mirna's mir34a patent application

Mirna Therapeutics, Inc. announced today that the United States Patent and Trademark Office has allowed patent claims related to the therapeutic application of the potent tumor suppressor microRNA, mir34a.

7 Apr 2011

Circadian's VGX-100 neutralises VEGF-C and inhibits tumour growth in mouse models of human cancers

Circadian Technologies Limited today released data at the American Association for Cancer Research (AACR) annual conference in Orlando, Florida (U.S.A.) demonstrating that its lead anti-cancer therapeutic, VGX-100, significantly inhibits tumour growth and spread in a variety of different mouse models of human cancer.

7 Apr 2011

A2AAR-selective agonists may prevent permanent vision damage from traumatic optic nerve injury

Scientists want to protect the optic nerve when the eye takes a blow on the battlefield or in a car wreck.

7 Apr 2011

FDA approves Horizant Extended-Release Tablets for Restless Legs Syndrome

GlaxoSmithKline and XenoPort, Inc. announced Wednesday that the U.S. Food and Drug Administration (FDA) has approved Horizant™ (gabapentin enacarbil) Extended-Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome in adults. Horizant is not recommended for patients who are required to sleep during the daytime and remain awake at night.

7 Apr 2011

Workers exposed to welding fumes may face risk of developing brain damage

New research suggests that workers exposed to welding fumes may be at risk for developing brain damage in an area of the brain also affected in Parkinson's disease. The study is published in the April 6, 2011, online issue of Neurology, the medical journal of the American Academy of Neurology.

7 Apr 2011

VBL's VB-111 preclinical data against metastatic cancer presented at AACR meeting

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced preclinical data demonstrating VB-111's potential utility as a targeted cancer treatment.

7 Apr 2011

Brazil's Ministry of Health, PharmaPraxis sign deal to manufacture biologic drugs

PharmaPraxis, from Axis Biotec, Cryopraxis, Silvestre Labs and CellPraxis Group, announces the formalization of an agreement with Brazil's Ministry of Health to manufacture biologic drugs.

7 Apr 2011

FDA approves Covidien's PMA application for Pipeline Embolization Device

Covidien, a leading global provider of healthcare products, today announced that it received Premarket Approval from the U.S. Food and Drug Administration for the Pipeline Embolization Device, indicated for the endovascular treatment of adults with large or giant wide-necked intracranial aneurysms in the internal carotid artery from the petrous to the superior hypophyseal segments.

7 Apr 2011

Medical Condition News

Affectionate communication may have positive impact on alexithymia sufferers

Robotic-assisted keyhole surgery tested for bowel cancer

Elevated BMI linked to high risk of obesity-related disorders in young adults

Vegans at increased risk of developing blood clots and atherosclerosis

Supplements are less well regulated than drugs and may have side effects, drug interactions and toxicities

EACPR to host sessions on Cardiovascular prevention in Russia at EuroPRevent meeting

Positive results from Neuros Medical Electrical Nerve Block technology study in chronic pain

New insight into Huntington's disease

Scientists identify cellular switch that may help treat cardiovascular disease, cancer

New Pipeline Embolization Device receives FDA approval for treatment of brain aneurysms

Cernostics, Definiens enter partnership to develop unique cancer assay

ALR announces medical research grant awards to cure lupus

USPTO issues notice of allowance to Mirna's mir34a patent application

Circadian's VGX-100 neutralises VEGF-C and inhibits tumour growth in mouse models of human cancers

A2AAR-selective agonists may prevent permanent vision damage from traumatic optic nerve injury

FDA approves Horizant Extended-Release Tablets for Restless Legs Syndrome

Workers exposed to welding fumes may face risk of developing brain damage

VBL's VB-111 preclinical data against metastatic cancer presented at AACR meeting

Brazil's Ministry of Health, PharmaPraxis sign deal to manufacture biologic drugs

FDA approves Covidien's PMA application for Pipeline Embolization Device

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News